Table 2.
Association between miR-155-5p expression and clinical features of participants.
| Variable | Total Number | overexpressed | under expressed | P-value* |
|---|---|---|---|---|
| Gender | - | |||
| Female | 5 | 3 | 2 | |
| Male | 22 | 14 | 8 | |
| Recurrence | 1.00 | |||
| NO | 12 | 5 | 7 | |
| Yes | 12 | 4 | 8 | |
| Diabetes | 0.011 | |||
| NO | 18 | 4 | 14 | |
| Yes | 9 | 7 | 2 | |
| Hypertension | 0.252 | |||
| NO | 14 | 10 | 4 | |
| Yes | 13 | 6 | 7 | |
| Cardiovascular diseases | 0.4 | |||
| NO | 19 | 9 | 10 | |
| Yes | 8 | 2 | 6 | |
| Hyperlipidemia | 0.37 | |||
| NO | 22 | 8 | 14 | |
| Yes | 5 | 3 | 2 | |
| Smoking | 0.704 | |||
| NO | 14 | 5 | 9 | |
| Yes | 13 | 6 | 7 | |
| Number of Tumors | 1.00 | |||
| singular | 15 | 6 | 9 | |
| Multiple | 12 | 7 | 5 | |
| Grade | 0.618 | |||
| Low grade | 5 | 1 | 4 | |
| High grade | 22 | 10 | 12 | |
| Stage | 0.692 | |||
| T1 | 9 | 3 | 6 | |
| Ta | 18 | 8 | 10 |
Two-sided fisher exact test and Χ2 test were applied to compare the frequencies of participants with under/overexpression of miR-155-5p with different clinical features.